Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Kendra J Grubb Added: 5 months ago
TCT 23 - We are joined by Dr Kendra Grubb (Emory School of Medicine, Atlanta, GA, US) for a concise and insightful summary of the late-breaking trials that are expected to have an impact on interventional science concerning structural heart disease and clinical practice. Trials covered in detail include: PARTNER 3 & EVOLUT Low-Risk ALIGN-AR TENDYNE APOLLO TRILUMINATE Recorded remotely… View more
Foreword

Article

Author(s): Ankur Kalra Added: 3 years ago
I am excited to bring you the Spring 2019 issue of US Cardiology Review. This is my second issue as the incumbent Editor-in-Chief, and my first as Member of the Staff, Department of Cardiovascular Medicine at the Cleveland Clinic. I have made a concerted effort in reaching out to colleagues who I have trained and worked with at different stages in my career to contribute to this issue. They are… View more
Author(s): Mirvat Alasnag Added: 5 months ago
TCT 23 - We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of the late-breaking trials that are expected to have an impact on interventional science and clinical practice. Trials covered in detail include: Agent IDE ALIGN-AR PARTNER 3 EVOLUT Low-Risk TRISCEND Recorded remotely from Jeddah, 2023. Editor: Jordan Rance Video Specialist:… View more
Author(s): James Gammie Added: 2 years ago
In this short interview, Dr James Gammie (University of Maryland Medical Center, MD, US) discusses the findings from surgical trial assessing the benefit of concomitant tricuspid repair during mitral valve surgery. The trial, presented at AHA 2021, demonstrated that at 2 years, TA had no impact on MACCE, survival, or QOL. Discussion Points 1. Reasoning for this Study 2. Study Design and… View more
Author(s): Michael F Morris , Philip A Araoz Added: 3 years ago
Mitral valve dysfunction is the most common cause of valvular disease in the US.1 Although echocardiography is the primary non-invasive modality for visualizing the mitral valve, advances in technology continue to allow for improved evaluation of mitral disease with magnetic resonance imaging (MRI) and computed tomography (CT).2,3 Currently, the role for MRI and CT assessment of the mitral valve… View more